PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AC Immune SA (ACIU)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINCH0329023102
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$344.17M
EPS (TTM)-$0.69
Total Revenue (TTM)$14.80M
Gross Profit (TTM)-$12.25M
EBITDA (TTM)-$37.68M
Year Range$2.20 - $5.14
Target Price$10.39
Short %1.38%
Short Ratio2.17

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


AC Immune SA

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in AC Immune SA, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%150.00%FebruaryMarchAprilMayJuneJuly
-77.78%
154.31%
ACIU (AC Immune SA)
Benchmark (^GSPC)

S&P 500

Returns By Period

AC Immune SA had a return of -30.40% year-to-date (YTD) and 19.18% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-30.40%15.41%
1 month-14.50%0.33%
6 months-16.14%13.74%
1 year19.18%21.39%
5 years (annualized)-9.09%13.11%
10 years (annualized)N/A10.77%

Monthly Returns

The table below presents the monthly returns of ACIU, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-35.80%12.77%-18.23%-16.22%87.50%-14.19%-30.40%
202321.57%-7.66%2.18%-17.09%12.37%35.55%1.52%8.33%-12.31%5.26%10.33%51.06%145.10%
2022-10.71%-7.92%-1.72%-10.50%-12.29%14.97%-2.49%-14.20%4.64%-13.61%-6.59%-20.00%-58.79%
202115.67%26.92%0.26%-11.17%-9.91%30.21%-8.20%11.68%-17.47%-4.02%-20.34%-3.51%-4.26%
20209.04%-26.05%0.58%2.89%8.86%-13.05%-2.97%18.84%-37.11%-1.23%14.94%-6.68%-39.32%
2019-56.40%12.14%9.31%-5.74%6.30%9.68%3.06%-8.74%-5.17%12.53%43.63%6.50%-9.84%
20184.38%-20.88%-2.18%-0.29%1.65%-11.07%3.54%-3.73%-13.89%3.50%34.30%-15.02%-26.17%
2017-7.40%3.49%-16.72%-7.82%-6.81%-1.12%-16.70%6.96%42.47%5.28%-0.60%9.50%-1.39%
20165.17%-17.30%-14.90%11.99%-17.11%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ACIU is 55, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of ACIU is 5555
ACIU (AC Immune SA)
The Sharpe Ratio Rank of ACIU is 5353Sharpe Ratio Rank
The Sortino Ratio Rank of ACIU is 6060Sortino Ratio Rank
The Omega Ratio Rank of ACIU is 5656Omega Ratio Rank
The Calmar Ratio Rank of ACIU is 5555Calmar Ratio Rank
The Martin Ratio Rank of ACIU is 5454Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for AC Immune SA (ACIU) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


ACIU
Sharpe ratio
The chart of Sharpe ratio for ACIU, currently valued at 0.20, compared to the broader market-2.00-1.000.001.002.003.000.20
Sortino ratio
The chart of Sortino ratio for ACIU, currently valued at 1.00, compared to the broader market-4.00-2.000.002.004.001.00
Omega ratio
The chart of Omega ratio for ACIU, currently valued at 1.11, compared to the broader market0.501.001.502.001.11
Calmar ratio
The chart of Calmar ratio for ACIU, currently valued at 0.18, compared to the broader market0.001.002.003.004.005.006.000.18
Martin ratio
The chart of Martin ratio for ACIU, currently valued at 0.60, compared to the broader market-30.00-20.00-10.000.0010.0020.000.60
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.82, compared to the broader market-2.00-1.000.001.002.003.001.82
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.59, compared to the broader market-4.00-2.000.002.004.002.59
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.32, compared to the broader market0.501.001.502.001.32
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.45, compared to the broader market0.001.002.003.004.005.006.001.45
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 6.82, compared to the broader market-30.00-20.00-10.000.0010.0020.006.82

Sharpe Ratio

The current AC Immune SA Sharpe ratio is 0.20. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of AC Immune SA with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.503.00FebruaryMarchAprilMayJuneJuly
0.20
1.82
ACIU (AC Immune SA)
Benchmark (^GSPC)

Dividends

Dividend History


AC Immune SA doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%FebruaryMarchAprilMayJuneJuly
-81.97%
-2.86%
ACIU (AC Immune SA)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the AC Immune SA. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the AC Immune SA was 91.09%, occurring on Dec 22, 2022. The portfolio has not yet recovered.

The current AC Immune SA drawdown is 81.97%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-91.09%Sep 29, 20161570Dec 22, 2022

Volatility

Volatility Chart

The current AC Immune SA volatility is 13.80%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%FebruaryMarchAprilMayJuneJuly
13.80%
2.76%
ACIU (AC Immune SA)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of AC Immune SA over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

P/E Ratio

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for AC Immune SA.


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items